000 | 027380000a22008050004500 | ||
---|---|---|---|
001 | 002049 | ||
005 | 20230526120531.0 | ||
020 | _a92-4-154189 X | ||
046 | _j19850000 | ||
245 | _aAcrylamide | ||
260 | _bWorld Health Organization | ||
260 | _c1985 | ||
270 | _bGeneva | ||
270 | _dCH | ||
300 | _a121 p. | ||
300 | _btabls. | ||
490 |
_aEnvironmental Health Criteria _n49 |
||
505 | _aEnvironmental health criteria for acrylamide | ||
505 | _aSummary and recommendations for further research | ||
505 | _aSummary | ||
505 | _aRecommendations for further research | ||
505 | _aProperties and analytical methods | ||
505 | _aIdentity | ||
505 | _aChemical physical and properties | ||
505 | _aSampling and analytical methods | ||
505 | _aSources in the environment | ||
505 | _aProduction levels, processes and uses | ||
505 | _aRelease into the environment | ||
505 | _aDisposal of wastes | ||
505 | _aEnvironmental transport, distribution, and transformation | ||
505 | _aTransport in the environment | ||
505 | _aBiomagnification and bioconcentration | ||
505 | _aTransformation | ||
505 | _aEnvironmetal levels and exposure | ||
505 | _aEnvironmental levels | ||
505 | _aGeneral population exposure | ||
505 | _aOccupational exposure | ||
505 | _aKinetics and metabolism | ||
505 | _aExperimental animal studies | ||
505 | _aHuman studies | ||
505 | _aEffects on animals | ||
505 | _aNeurological effects | ||
505 | _aIn vitro toxicity studies | ||
505 | _aEffects on other organs | ||
505 | _aGenotoxic effects and carcinogenicity studies | ||
505 | _aTeratogenicity and reproductive studies | ||
505 | _aFactors modifying effects | ||
505 | _aDose-response and dose-effect relationships | ||
505 | _aEffects on man | ||
505 | _aClinical studies and case reports | ||
505 | _aEpidemiological studies | ||
505 | _aDose-effects and dose-response relationships | ||
505 | _aEffects on organisms in the environment | ||
505 | _aAquatic organisms | ||
505 | _aTerrestrial plants | ||
505 | _aMicroorganisms | ||
505 | _aStructure-neurotoxicity relationships | ||
505 | _aEvaluation of health risks for man and effects on the environment from exposure to acrylamide | ||
505 | _aGeneral considerations; assessment of exposure | ||
505 | _aAssessment of adverse effects | ||
505 | _aExposure of the environment | ||
505 | _aOccupational exposure | ||
546 | _aInglés | ||
650 | _aACRILAMIDA-TOXICOLOGÍA | ||
650 | _aACRILAMIDA-EFECTO FISIOLÓGICO | ||
650 | _aACRILAMIDA-ASPECTOS AMBIENTALES | ||
710 | _aWorld Health Organization | ||
852 |
_aWA670 _bW46ac |
||
942 | _cLB | ||
999 |
_c4556 _d4556 |